Theravance Biopharma (TBPH) Return on Invested Capital (2019 - 2022)

Theravance Biopharma (TBPH) has 4 years of Return on Invested Capital data on file, last reported at 0.05% in Q4 2022.

• On a quarterly basis, Return on Invested Capital changed 0.0% year-over-year to 0.05% in Q4 2022; TTM through Dec 2022 was 0.05%, a 0.0% change from a year earlier, with the FY2021 full-year figure at 0.14%, up 6.0% from the prior year.
• Return on Invested Capital for Q4 2022 stood at 0.05%, down from 0.04% in the prior quarter.
• Over the last five years, Return on Invested Capital for TBPH reached as high as 0.04% in Q3 2022 and fell as low as 0.21% in Q3 2020.
• Historically, Return on Invested Capital has averaged 0.09% across 4 years, with a median of 0.07% in 2019.
• Across the five-year window, Return on Invested Capital decreased 13 bps in 2020 and grew 15 bps in 2021, its largest moves.
• Year by year, Return on Invested Capital stood at 0.07% in 2019, then tumbled by 176 bps to 0.2% in 2020, then soared by 74 bps to 0.05% in 2021, then slipped by 1 bps to 0.05% in 2022.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.05% in Q4 2022, 0.04% in Q3 2022, and 0.04% in Q2 2022.